BioVie Inc. Announces Pricing of Public Offering
CARSON CITY, Nev., March 04, 2024 (GLOBE NEWSWIRE) — BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company […]
Coherus Completes Divestiture of Ophthalmology Franchise
– Upfront cash payment of $170 million strengthens capital structure – – Transaction solidifies Coherus’ strategic focus in oncology – […]
Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease
Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease VIVIAD Phase 2b study did […]
Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend from March 31, 2024 to September 30, 2024
PALO ALTO, Calif., March 02, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused […]
Passing of the Right Honorable Brian Mulroney
TORONTO, March 01, 2024 (GLOBE NEWSWIRE) — The Board of Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) is deeply saddened by the passing […]
Brookfield Business Partners Completes 2023 Annual Filings
BROOKFIELD, NEWS, March 01, 2024 (GLOBE NEWSWIRE) — Brookfield Business Partners (NYSE: BBU, BBUC; TSX: BBU.UN, BBUC) announced today the […]
Earth Alive announces the departure of its Chief Legal Officer
MONTREAL, March 01, 2024 (GLOBE NEWSWIRE) — Earth Alive Clean Technologies Inc. (TSXV: EAC) (“Earth Alive” or the “Company”), a […]
Epsilon Energy Ltd. Announces the Following Headlines
Board declares dividend of $0.0625 per common share Company announces the timing of its 2023 year end earnings release and […]
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
CHARLOTTESVILLE, Va., March 01, 2024 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical […]
The Honest Company Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
LOS ANGELES, March 01, 2024 (GLOBE NEWSWIRE) — The Honest Company (NASDAQ: HNST), a personal care company dedicated to creating […]
